Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Bolus Volume on Opioid-Induced Swallowing Dysfunction
NCT03283020Phase 4Unknown
- Sponsor
- Region Örebro län
- Start
- Nov 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylnaltrexone in dysphagia, sponsored by Region Örebro län. Status: unknown.
02
Drugs
methylnaltrexone
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT03283020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283020.